Adma Biologics (ADMA) Cash from Financing Activities (2011 - 2026)
Adma Biologics (ADMA) recorded Cash from Financing Activities of -$26.77 million in Q3 2026, compared with -$27.83 million a year earlier.
Powered by 
Analysis
Adma Biologics (ADMA) Cash from Financing Activities (2011 - 2026) Analysis & Trends
On a TTM basis, Adma Biologics' Cash from Financing Activities came in at -$75.43 million as of Sep 30, 2026; for FY2025, it was -$44.02 million.
- Across earlier years, Cash from Financing Activities came in at -$58.3 million in FY2024, -$38.99 million in FY2023, $108.85 million in FY2022 (-10.1%) and $121.05 million in FY2021 (-15.9%).
- Quarterly Cash from Financing Activities has ranged from -$39 million in Q4 2023 to $62.74 million in Q4 2022 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$29.42 million (Q2 2026), -$10.13 million (Q1 2026) and -$9.12 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | -26.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -26.77 Mn |
| Jun 30, 2026 | -29.42 Mn |
| Mar 31, 2026 | -10.13 Mn |
| Dec 31, 2025 | -9.12 Mn |
| Sep 30, 2025 | -27.83 Mn |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | -7.13 Mn |
| Dec 31, 2024 | -31.03 Mn |
| Sep 30, 2024 | -25.47 Mn |
| Jun 30, 2024 | -362,000.00 |
| Mar 31, 2024 | -1.45 Mn |
| Dec 31, 2023 | -39.00 Mn |
| Sep 30, 2023 | 416,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | -650,000.00 |
| Dec 31, 2022 | 62.74 Mn |
| Sep 30, 2022 | -843,791.00 |
| Jun 30, 2022 | -319,041.00 |
| Mar 31, 2022 | 47.27 Mn |
| Dec 31, 2021 | 53.82 Mn |
API Access
Adma Biologics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();